发明申请
![Pyridine [3,4-b] Pyrazinones](/docs/US/2007-10-25/US20070249615A1/abs.jpg.600x600.jpg)
- 专利标题： Pyridine [3,4-b] Pyrazinones
- 专利标题（中）： 吡啶[3,4-b]吡嗪酮
-
申请号： US11737966申请日： 2007-04-20
-
公开(公告)号： US20070249615A1公开(公告)日： 2007-10-25
- 发明人: Robert Hughes , Andrew Bell , David Brown , Dafydd Owen , Michael Palmer , Christopher Phillips , David Brown , Yvette Fobian , John Freskos , Steven Heasley , E. Jacobsen , Todd Maddux , Brent Mischke , John Molyneaux , Joseph Moon , D. Rogier , Michael Tollefson , John Walker
- 申请人： Robert Hughes , Andrew Bell , David Brown , Dafydd Owen , Michael Palmer , Christopher Phillips , David Brown , Yvette Fobian , John Freskos , Steven Heasley , E. Jacobsen , Todd Maddux , Brent Mischke , John Molyneaux , Joseph Moon , D. Rogier , Michael Tollefson , John Walker
- 专利权人： Pfizer Inc
- 当前专利权人： Pfizer Inc
- 主分类号： A61K31/498
- IPC分类号： A61K31/498 ; C07D487/02
![Pyridine [3,4-b] Pyrazinones](/abs-image/US/2007/10/25/US20070249615A1/abs.jpg.150x150.jpg)
摘要：
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: wherein R2, R6A, R6B and R8 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, synthetic methods, and intermediates are also disclosed.
公开/授权文献
- US07902195B2 Pyridine [3,4-b] pyrazinones 公开/授权日：2011-03-08
信息查询
IPC分类:
